Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
8.63
+0.15 (1.77%)
At close: Jan 8, 2026, 4:00 PM EST
8.70
+0.07 (0.81%)
Pre-market: Jan 9, 2026, 8:11 AM EST
Zevra Therapeutics Market Cap
Zevra Therapeutics has a market cap or net worth of $485.85 million as of January 9, 2026. Its market cap has increased by 7.20% in one year.
Market Cap
485.85M
Enterprise Value
349.06M
1-Year Change
7.20%
Ranking
Category
Stock Price
$8.63
Market Cap Chart
Since April 16, 2015, Zevra Therapeutics's market cap has increased from $137.80M to $485.85M, an increase of 252.57%. That is a compound annual growth rate of 12.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 485.80M | -3.69% |
| Dec 31, 2025 | 504.40M | 13.30% |
| Dec 31, 2024 | 445.20M | 87.69% |
| Dec 29, 2023 | 237.20M | 49.75% |
| Dec 30, 2022 | 158.40M | -48.50% |
| Dec 31, 2021 | 307.60M | 505.51% |
| Dec 31, 2020 | 50.80M | 303.17% |
| Dec 31, 2019 | 12.60M | -73.25% |
| Dec 31, 2018 | 47.10M | -20.71% |
| Dec 29, 2017 | 59.40M | 37.50% |
| Dec 30, 2016 | 43.20M | -84.95% |
| Dec 31, 2015 | 287.00M | 108.27% |
| Apr 16, 2015 | 137.80M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 952.72B |
| Johnson & Johnson | 493.40B |
| AbbVie | 395.77B |
| UnitedHealth Group | 316.11B |
| AstraZeneca | 293.89B |
| Merck & Co. | 270.22B |
| Novartis AG | 268.87B |
| Novo Nordisk | 253.02B |